William Blair’s biopharma investment banking team’s Quarterly Rx was cited by the The Wall Street Journal in its coverage of IPO activity and other investment trends in the sector.
Investment Banking
The Wall Street Journal Cites Biopharma Investment Banking’s Quarterly Report
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
-
-
-
William Blair Advises Capital A on Raising a Single-Asset Continuation Vehicle for DJZ
William Blair served as the exclusive financial advisor to Capital A Investment Partners (Capital A) on both the raising of its single-asset continuation fund and the concurrent refinancing process of De Jong Zuurmond (DJZ).